Non-Small Cell Lung Cancer (NSCLC) Market Presents and Future Statistics and Growth Forecast to 2030

The global Non-Small Cell Lung Cancer (NSCLC) market size is expected to reach USD 13.51 Billion in 2030 and register a revenue CAGR of 6.8% over the forecast period, according to latest report by Reports and Data. Excessive consumption of tobacco, increase in active and passive smokers, and exposure to high levels of pollution are key factors propelling market revenue growth of NSCLC.

NSCLC accounts for a significant percentage of lung cancer cases across the world, and this high number has encouraged market players to focus on development of new therapies and improving efficacy of existing medicines for the disease. Lung cancer is one of the most common malignancies and results in a significant number of deaths globally. This has created a need to treat the disease and reduce mortality rate.

Market Overview:

The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.

Key Players covered in this report are

Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, Boehringer Ingelheim International GmbH, F.Hoffmann-La Roche Ltd, Merck KGaA, Sanofi, and Astellas Pharma Inc.

Type Outlook (Revenue, USD Billion; 2019-2030)

  • Adenocarcinoma
  • Squamous cell carcinoma
  • Large cell carcinoma
  • Others

Therapy Outlook (Revenue, USD Billion; 2019-2030)

  • Chemotherapy
  • Targeted therapy
  • Surgery
  • Radiotherapy
  • Laser therapy
  • Photodynamic therapy
  • Immunotherapy
  • Others

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Request a sample Report of Non-Small Cell Lung Cancer (NSCLC) Market @ https://www.reportsanddata.com/sample-enquiry-form/1475

Major Points covered in this report are as below:

• The Non-Small Cell Lung Cancer (NSCLC) industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Non-Small Cell Lung Cancer (NSCLC) Market report provides key statistics on the market status of the Non-Small Cell Lung Cancer (NSCLC) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Get More Related Reports:

Intra-Aortic Balloon Pump (IABP) Market @ https://www.reportsanddata.com/report-detail/intra-aortic-balloon-pump-iabp-market

Epinephrine Market @ https://www.reportsanddata.com/report-detail/epinephrine-market

Microplate Readers Market @ https://www.reportsanddata.com/report-detail/microplate-readers-market

Pet Insurance Market @ https://www.reportsanddata.com/report-detail/pet-insurance-market

Artificial Tears Market @ https://www.reportsanddata.com/report-detail/artificial-tears-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Comments are closed